- 米国企業
- RedHill Biopharma Ltd.
RedHill Biopharma Ltd.RDHL
時価総額
PER
2017年 12月31日 | 2018年 12月31日 | 2019年 12月31日 | 2020年 12月31日 | 2021年 12月31日 | 2022年 12月31日 | |
Revenue | 4 | 8 | 6 | 64 | 86 | 62 |
Cost of sales | 2 | 3 | 2 | 37 | 49 | 33 |
GROSS PROFIT | 2 | 6 | 4 | 27 | 36 | 28 |
RESEARCH AND DEVELOPMENT EXPENSES | 33 | 25 | 17 | 16 | 29 | 7 |
Sales and marketing expense | 12 | 12 | 18 | 49 | 56 | 35 |
GENERAL AND ADMINISTRATIVE EXPENSES | 8 | 8 | 11 | 25 | 32 | 29 |
OPERATING LOSS | -52 | -39 | -43 | -64 | -81 | -43 |
Finance income | 7 | 1 | 1 | 0 | 0 | 14 |
Finance costs | 0 | 0 | 0 | 13 | 17 | 42 |
FINANCIAL EXPENSES, net | 6 | 1 | 1 | -12 | -17 | -29 |
LOSS AND COMPREHENSIVE LOSS FOR THE YEAR | -46 | -39 | -42 | -76 | -98 | -72 |
LOSS PER ORDINARY SHARE, basic (U.S. dollars) | -0.26 | -0.17 | - | - | -0.21 | -0.12 |
LOSS PER ORDINARY SHARE, diluted (U.S. dollars) | -0.26 | -0.17 | - | - | -0.21 | -0.12 |